Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Liposomal Rhenium Re 186

Known as: Rhenium-186 Liposome, Liposomal Rhenium-186, 186RNL 
A therapeutic preparation consisting of the beta-emitting radioisotope rhenium Re 186 encapsulated in a nanoliposome, with potential antineoplastic… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND: Using a special methodology for radiolabeling lipid nanoparticles with therapeutic radionuclides, we have developed… Expand
Highly Cited
2012
Highly Cited
2012
Although external beam radiation is an essential component to the current standard treatment of primary brain tumors, its… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2012
2012
UNLABELLED Radiosynoviorthesis (RSO) with the nuclides rhenium-186 sulphide (186Re) and erbium-169 citrate (169Er) is an… Expand
2010
2010
PURPOSE Minimally invasive interventional cancer therapy with drug-carrying lipid nanoparticles (ie, liposomes) via convection… Expand
Highly Cited
2003
Highly Cited
2003
UNLABELLED Liposomes are important carriers for controlling the spatial and temporal distribution of drug molecules or other… Expand
1999
1999
Post-therapeutic rhenium-186 HEDP scintigraphy revealed unexpected tracer uptake in the stomach of a 69-year-old man with… Expand
Review
1998
Review
1998
The skeleton is a common site for metastases in patients with prostate and breast cancer. Beside analgesic therapy and external… Expand